Turn Therapeutics (TTRX) Operating Leases (2024 - 2026)

Turn Therapeutics' Operating Leases history runs 3 years deep, the most recent figure standing at $21539.0 for Q1 2026.

• In Q1 2026, Operating Leases changed N/A year-over-year to $21539.0; the TTM figure through Mar 2026 stood at $21539.0 (changed N/A YoY), while the FY2025 annual figure was $34081.0, down 57.6% from the prior year.
• Operating Leases was $21539.0 for Q1 2026 at Turn Therapeutics, down from $34081.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $80376.0 in Q4 2024 to a low of $21539.0 in Q1 2026.
• Historically, Operating Leases has averaged $45585.0 across 3 years, with a median of $40212.5 in 2025.
• Biggest YoY gain for Operating Leases was 57.6% in 2025; the steepest drop was 57.6% in 2025.
• A 3-year view of Operating Leases shows it stood at $80376.0 in 2024, then tumbled by 57.6% to $34081.0 in 2025, then slumped by 36.8% to $21539.0 in 2026.
• The last three Operating Leases figures came in at $21539.0 (Q1 2026), $34081.0 (Q4 2025), and $46344.0 (Q3 2025), per Business Quant data.